Immunocore Holdings annual gross profit
2021
2022
2023
2024
2025
Immunocore Holdings Gross Profit Growth & History (IMCR)
Immunocore Holdings's gross profit was $394.9M for fiscal 2025.
View full Immunocore Holdings company overviewImmunocore Holdings annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $394.9M | $87.5M | +28.44% |
| 2024 | 2024-12-31 | $307.5M | $59.1M | +23.79% |
| 2023 | 2023-12-31 | $248.4M | $75.1M | +43.35% |
| 2022 | 2022-12-31 | $173.3M | $169.2M | +4148.95% |
| 2021 | 2021-12-31 | $4.1M | — | — |
Immunocore Holdings quarterly gross profit
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $114.8M | $17.9M | +18.48% |
| Q1 2026 | 2026-03-31 | $106.2M | $13.2M | +14.18% |
| Q4 2025 | 2025-12-31 | $101.8M | $18.1M | +21.56% |
| Q3 2025 | 2025-09-30 | $103.2M | $23.4M | +29.30% |
| Q2 2025 | 2025-06-30 | $96.9M | $23.2M | +31.52% |
| Q1 2025 | 2025-03-31 | $93.0M | $22.8M | +32.44% |
| Q4 2024 | 2024-12-31 | $83.7M | $13.8M | +19.67% |
| Q3 2024 | 2024-09-30 | $79.8M | $15.2M | +23.58% |
| Q2 2024 | 2024-06-30 | $73.7M | $14.3M | +24.04% |
| Q1 2024 | 2024-03-31 | $70.3M | $15.8M | +29.05% |
| Q4 2023 | 2023-12-31 | $70.0M | — | — |
| Q3 2023 | 2023-09-30 | $64.6M | — | — |
| Q2 2023 | 2023-06-30 | $59.4M | — | — |
| Q1 2023 | 2023-03-31 | $54.4M | — | — |
Immunocore Holdings gross profit trends
Between the periods ended 2021-12-31 and 2025-12-31, Immunocore Holdings's gross profit increased from $4.1M to $394.9M, a change of $390.9M. The latest reported quarter, Q2 2026, shows $114.8M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Immunocore Holdings source filings ↗